These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Extracorporeal liver support: waiting for the deciding vote. Adham M ASAIO J; 2003; 49(6):621-32. PubMed ID: 14655724 [TBL] [Abstract][Full Text] [Related]
25. [Liver and artificial liver]. Chamuleau RA Ned Tijdschr Geneeskd; 1998 Jun; 142(23):1300-5. PubMed ID: 9752034 [TBL] [Abstract][Full Text] [Related]
26. Use of the molecular adsorbent recirculating system (MARS™) for the management of acute poisoning with or without liver failure. Wittebole X; Hantson P Clin Toxicol (Phila); 2011 Nov; 49(9):782-93. PubMed ID: 22077243 [TBL] [Abstract][Full Text] [Related]
27. Extracorporeal liver perfusion as hepatic assist in acute liver failure: a review of world experience. Pascher A; Sauer IM; Hammer C; Gerlach JC; Neuhaus P Xenotransplantation; 2002 Sep; 9(5):309-24. PubMed ID: 12199863 [TBL] [Abstract][Full Text] [Related]
29. New approaches to supporting the failing liver. Cao S; Esquivel CO; Keeffe EB Annu Rev Med; 1998; 49():85-94. PubMed ID: 9509251 [TBL] [Abstract][Full Text] [Related]
30. [Biological and non-biological elimination therapy of acute liver failure. Experimental study on large laboratory animal]. Ryska M; Lásziková E; Pantoflícek T; Kieslichová E; Ryska O; Prazák J; Koblihová E; Skibová J Cas Lek Cesk; 2008; 147(7):367-75. PubMed ID: 18678095 [TBL] [Abstract][Full Text] [Related]
31. The bioartificial liver: state-of-the-art. Dixit V; Gitnick G Eur J Surg Suppl; 1998; (582):71-6. PubMed ID: 10029369 [TBL] [Abstract][Full Text] [Related]
32. Liver replacement therapy. Tritto G; Davies NA; Jalan R Semin Respir Crit Care Med; 2012 Feb; 33(1):70-9. PubMed ID: 22447262 [TBL] [Abstract][Full Text] [Related]
33. Bioartificial liver systems: current status and future perspective. Park JK; Lee DH J Biosci Bioeng; 2005 Apr; 99(4):311-9. PubMed ID: 16233796 [TBL] [Abstract][Full Text] [Related]
34. Evidence for Galalpha(1-3)Gal expression on primary porcine hepatocytes: implications for bioartificial liver systems. van de Kerkhove MP; Germans MR; Deurholt T; Hoekstra R; Joziasse DH; van Wijk AC; van Gulik TM; Chamuleau RA; Roos A J Hepatol; 2005 Apr; 42(4):541-7. PubMed ID: 15763340 [TBL] [Abstract][Full Text] [Related]
35. Albumin Dialysis for Liver Failure: A Systematic Review. Tsipotis E; Shuja A; Jaber BL Adv Chronic Kidney Dis; 2015 Sep; 22(5):382-90. PubMed ID: 26311600 [TBL] [Abstract][Full Text] [Related]
37. Use of bioartificial and artificial liver support devices. Hughes RD; Williams R Semin Liver Dis; 1996 Nov; 16(4):435-44. PubMed ID: 9027956 [TBL] [Abstract][Full Text] [Related]
38. Liver support in fulminant liver failure after hemorrhagic shock. Faybik P; Hetz H; Krenn CG; Baker A; Germann P; Berlakovich G; Steininger R; Steltzer H Wien Klin Wochenschr; 2003 Sep; 115(15-16):595-8. PubMed ID: 14531174 [TBL] [Abstract][Full Text] [Related]
39. Assessment of the AMC-bioartificial liver in the anhepatic pig. Sosef MN; Abrahamse LS; van de Kerkhove MP; Hartman R; Chamuleau RA; van Gulik TM Transplantation; 2002 Jan; 73(2):204-9. PubMed ID: 11821731 [TBL] [Abstract][Full Text] [Related]
40. Progress in bioreactors of bioartificial livers. Yu CB; Pan XP; Li LJ Hepatobiliary Pancreat Dis Int; 2009 Apr; 8(2):134-40. PubMed ID: 19357025 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]